Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NJFY0812015 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Previous studies on animals suggest that inhalational anesthetics can reduce vascular tension in vitro resulting in vasodilation and decrease in blood pressure. This role for inhalational anesthetics has essential clinical implications such as the condition of sepsis or septic shock or other shock-associated states during which the blood vessel constricts strongly and leads to circulation dysfunction. The vasodilation property of these anesthetics including halothane, isoflurane, sevoflurane, desflurane and enflurane enables them to be better options than other general anesthetics in many clinical conditions needing the vasculature to be dilated. The investigators hypothesized that these inhalational anesthetics can evoke vasodilation measured with ultrasonography during general anesthesia in vivo as the in vitro studies displayed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Active Comparator | Halothane anesthesia: induction and maintenance with different doses |
|
| 2 | Experimental | Isoflurane anesthesia: induction and maintenance with different doses |
|
| 3 | Experimental | Sevoflurane anesthesia: induction and maintenance with different doses |
|
| 4 | Experimental | Desflurane anesthesia: induction and maintenance with different doses |
|
| 5 | Experimental | Enflurane anesthesia: induction and maintenance with different doses |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Halothane | Drug | Induction: 2-4% halothane pluses 3-5 L/min oxygen Maintenance: different doses from 0.5% to 3% with 1-2 L/min oxygen |
|
| Measure | Description | Time Frame |
|---|---|---|
| Ultrasonography of blood vessels including radial artery, brachial artery, femoral artery, popliteal artery | Ten min prior to anesthesia; 0 min of anesthesia; 0 min of the end of anesthesia induction; 5, 10, 20, 30, 60 min during maintenance of the anesthesia |
| Measure | Description | Time Frame |
|---|---|---|
| Blood flow volume during anesthesia of the vasculature | Ten min prior to anesthesia; 0 min of anesthesia; 0 min of the end of anesthesia induction; 5, 10, 20, 30, 60 min during maintenance of the anesthesia | |
| Blood pressure including systolic, diastolic and mean artery blood pressures |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| XiaoFeng Shen, MD | Nanjing Medical University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nanjing Maternal and Child Health Care Hospital | Nanjing | Jiangsu | 210004 | China |
Not provided
| ID | Term |
|---|---|
| D000783 | Aneurysm |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006221 | Halothane |
| D007530 | Isoflurane |
| D000077149 | Sevoflurane |
| D000077335 | Desflurane |
| D004737 | Enflurane |
| ID | Term |
|---|---|
| D006846 | Hydrocarbons, Halogenated |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D008738 | Methyl Ethers |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Isoflurane | Drug | Induction: 2-5% isoflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen |
|
|
| Sevoflurane | Drug | Induction: 3-8% sevoflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen |
|
|
| Desflurane | Drug | Induction: 2-8% desflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen |
|
|
| Enflurane | Drug | Induction: 2-5% enflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen |
|
|
| Ten min prior to anesthesia; 0 min of anesthesia; 0 min of the end of anesthesia induction; 5, 10, 20, 30, 60 min during maintenance of the anesthesia |
| The time interval of between the initiation of the inhalational anesthetics delivered to the beginning of decreasing of blood pressure | From the beginning of anesthesia (0 min) till the first time of blood pressure decreased, this measure would be varied according to different individuals |
| The total dose of phenylephrine required to maintain baseline arterial blood pressure | From the beginning of anesthesia (0 min) to 20 min after anesthesia begun |
| Regression and correlation analyses between different doses of the anesthetics and the extent of vasodilation | Forty eight hours after operation |
| D004987 |
| Ethers |
| D006845 | Hydrocarbons, Fluorinated |
| D005019 | Ethyl Ethers |